Dunlop's 4 BC Vitamin Solution for Injection

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Ascorbic Acid, Nicotinamide, Pyridoxine Hydrochloride, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

제공처:

Norbrook Laboratories Limited

ATC 코드:

QA11EB

INN (국제 이름):

Ascorbic Acid, Nicotinamide, Pyridoxine Hydrochloride, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

약제 형태:

Solution for injection

처방전 유형:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

치료 그룹:

Cattle, Horses, Sheep

치료 영역:

Vitamin

승인 상태:

Authorized

승인 날짜:

1998-12-21

제품 특성 요약

Revised 13 November 2008
AN: 00666/2008
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Dunlop’s 4 BC Vitamin Solution for Injection.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Dunlop’s 4BC Vitamin Injection contains:
_ACTIVE SUBSTANCE_
Thiamine Hydrochloride.
3.5 %w/v
Riboflavin Sodium Phosphate
0.05 %w/v
Pyridoxine Hydrochloride
0.7 %w/v
Nicotinamide
2.3 %w/v
Ascorbic Acid
7.0 %w/v
_EXCIPIENTS_
Chlorocresol (as preservative)
0.1 %w/v
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection
A clear pale yellow liquid.
4.
CLINICAL PARTICULARS
4.1
_TARGET SPECIES_:
Horses
Cattle
Sheep
4.2
_INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:_
For the treatment of cerebrocortical necrosis in cattle and sheep, the
treatment of bracken poisoning in horses and for the treatment of
Vitamin B deficiencies in horses, cattle and sheep.
4.3
_CONTRAINDICATIONS:_
None.
4.4
_SPECIAL WARNINGS FOR EACH TARGET SPECIES:_
None
Revised 13 November 2008
AN: 00666/2008
4.5
_SPECIAL PRECAUTIONS FOR USE:_
SPECIAL PRECAUTIONS FOR USE IN ANIMALS:
None
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT TO THE ANIMALS:
Care should be taken to avoid accidental self-injection.
Wash hands after use.
4.6
_ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS):_
Anaphylactic reactions, particularly in the horse, may occur following
intravenous administration. When this route is used, the product
should be given slowly and may be diluted with sterile saline or
dextrose saline solution.
There may be slight irritation at the injection site when the product
is
given by the subcutaneous or intramuscular routes.
4.7
_USE DURING PREGNANCY, LACTATION OR LAY:_
Can be safely administered to pregnant and lactating animals.
4.8
_INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF _
_INTERACTION:_
None.
4.9
_AMOUNT TO BE ADMINISTERED AND ADMINISTRATION ROUTE:_
Administer by subcutaneous, deep intramuscular or slow intravenous
injection. The dose should be repeated d